Medicine, Health Professions
Millions of people in the United States live with serious illnesses such as cancer, heart disease, chronic obstructive pulmonary disorder (COPD), amyotrophic lateral sclerosis, Parkinsonâ€™s disease, and dementiaâ€”often for many years. Those facing serious illness have a range of interconnected medical and non-medical needs, and the way their care is financed has a large impact on the care they receive. Medicare is the predominant payer, but both Medicaid and private payers also play significant roles in financing care for serious illness. In an effort to address the complex needs of people with serious illness, public and private health care payers are testing innovative financing strategies and alternative payment models. These innovative approaches signal a gradual transition from the traditional-fee-for-service system that pays providers based on the quantity of services to a system based on the value of care provided and a heightened focus on improved quality of care at lower cost.
To explore this evolving financing and payment landscape for serious illness care within public- and private-sector programs, the Roundtable on Quality Care for People with Serious Illness developed a workshop, Financing and Payment Strategies to Support High-Quality Care for People with Serious Illness. The workshop convened clinicians, researchers, policy analysts, and patient advocates, as well as representatives from academia, government and private health care plans, and insurers to discuss challenges and opportunities in financing high-quality care for people with serious illness. This publication summarizes the presentations and discussions from the workshop.
Equip yourself to safely administer more than 400 intravenous drugs with the #1 IV drug handbook on the market! Now in its 35th edition, Gahart’s 2019 Intravenous Medications: A Handbook for Nurses and Health Professionals continues to be the most proven resource for comprehensive drug coverage, unparalleled accuracy, and an intuitive quick-access format. In addition to updating drug interactions, precautions, alerts, and patient teaching instructions for all existing IV drugs, this new 35th edition includes over a dozen new monographs of the most recent IV drugs to be approved by the FDA. When being inaccurate or out-of-date is not an option, Gahart’s annual publication and 40-year history of impeccable accuracy offers the confidence and proven guidance you need to safely and effectively administer any IV drug available today.
- Annual publication prevents users from referencing outdated information.
- 40-year history of impeccable accuracy reinforces the importance of safe IV drug administration.
- Monographs on more than 400 IV drugs offers an impressive breadth of coverage that goes well beyond any comparable drug reference.
- The perfect depth of information contains everything that is needed by today’s clinicians for safe administration of IV drugs ― nothing less, nothing more.
- Proven, clinically-optimized page layout keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page.
- Highlighted Black Box Warnings and relevant content make locating critical information fast and easy.
- Special circumstances in blue-screened text call attention to important circumstances that may not warrant black box warnings.
- Convenient, alphabetical format organizes all drug monographs by generic name, allowing users to find any drug in seconds.
- Dilution and dosage charts within monographs provide quick access to essential clinical information.
- Life stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients.
- Additional drug monographs not included in the printed guide are housed on the companion Evolve website. (Drugs found in ebook formats.)
- NEW! Over a dozen new drug monographs provide current, clinically relevant drug information for the most recent IV drugs to be approved by the FDA.
- NEW! Updates on drug interactions, precautions, alerts, and more have been made throughout the guide to reflect all changes to existing medications.
The closest you can get to seeing the USMLE Step 2 CK without actually taking it
Medicine: PreTest Self-Assessment & Review is the perfect way for you to assess your knowledge of medicine/internal medicine for the USMLE Step 2 CK and shelf exams. It delivers 500 USMLE-style questions and answers that address the clerkship’s core competencies along with detailed explanations of both correct and incorrect answers. All questions have been reviewed by students who recently passed the boards and completed their clerkship to ensure they match the style and difficulty level of the exam.
- 500 USMLE-style questions and answers
- Detailed explanations for right and wrong answers
- Targets what you really need to know for exam success
- Student tested and reviewed